Fund Holdings — B Group, Inc.

Total Portfolio Value:
$134.89M
Total Bought:
$43.63M
Total Sold:
$878.3K
Net Transaction:
+$42.75M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc2,457,5423,207,542+750,000$44.83M$28.90M21.43%-$15.93M
Palisade Bio, Inc.(PALI)4,500,00011,414,285+6,914,285$10.57M$19.97M14.81%+$9.40M
Praxis Precision Medicines, Inc.(PRAX)33,23733,2370$9.80M$10.71M7.94%+$912.4K
Cellectis S.A.ADS(CLLS)3,281,5013,281,5010$15.88M$10.40M7.71%-$5.48M
Zai Lab LimitedADR(ZLAB)400,000450,646+50,646$7.06M$8.48M6.28%+$1.42M
Taysha Gene Therapies, Inc.(TSHA)1,800,5561,800,5560$9.90M$8.05M5.97%-$1.85M
NRx Pharmaceuticals, Inc.(NRXP)03,000,000+3,000,000$0$6.39M4.74%+$6.39M
Structure Therapeutics IncADS90,000127,500+37,500$6.26M$6.15M4.56%-$114.0K
Iovance Biotherapeutics, Inc.(IOVA)1,500,0001,500,0000$4.09M$5.26M3.90%+$1.17M
Spyre Therapeutics, Inc.(SYRE)100,000100,0000$3.28M$5.04M3.74%+$1.77M
Bright Minds Biosciences Inc.(DRUG)067,500+67,500$0$4.93M3.65%+$4.93M
Assembly Biosciences Inc175,706175,7060$5.98M$4.88M3.61%-$1.10M
Aura Biosciences, Inc.(AURA)572,576597,576+25,000$3.12M$4.00M2.96%+$877.2K
Oruka Therapeutics, Inc.(ORKA)75,00075,0000$2.27M$3.68M2.73%+$1.41M
Sight Sciences, Inc.(SGHT)920,000970,000+50,000$7.30M$3.66M2.71%-$3.64M
Ultragenyx Pharmaceutical Inc.(RARE)135,000135,0000$3.10M$2.83M2.10%-$276.8K
Apogee Therapeutics Inc20,0007,500-12,500$1.51M$631.3K0.47%-$878.3K
Foghorn Therapeutics Inc.(FHTX)0102,000+102,000$0$487.6K0.36%+$487.6K
Soleno Therapeutics Inc07,500+7,500$0$251.1K0.19%+$251.1K
Replimune Group, Inc.(REPL)026,000+26,000$0$198.9K0.15%+$198.9K
Page 1 of 1